Atorvastatin
Atorvastatin Visual Mnemonic Guide
Panel 1: The Epidemic of the Fatty Bricks
The Liver-castle produces fatty bricks and blobs that cause the population to become overweight, sluggish couch potatoes.
Pathophysiology & Drug Class: The liver synthesizes cholesterol via hepatic production pathways. Elevated levels lead to dyslipidemia, hypercholesterolemia, and increased ASCVD risk.
Panel 2: The Static Actor's Stand (Mechanism of Action)
The Static Actor stands completely still directly in front of the production intake line for hours, shutting down production.
Drug Name & Mechanism: "Static Actor" represents Atorvastatin, a competitive HMG-CoA reductase inhibitor that blocks conversion to mevalonate. Standing for many hours highlights its long elimination half-life (15–30 hours).
Panel 3: Public Pressure & Recall (Clearance Effect)
Reporters pressure the Liver-castle into issuing a total recall of all distributed fatty bricks back from the public.
Lipid & Receptor Effects: Inhibiting hepatic synthesis lowers intrahepatic cholesterol, triggering upregulation of LDL receptors on hepatocytes and increased clearance of circulating LDL and triglycerides from plasma.
Panel 4: The People's Recovery (Clinical Indications)
With brick production halted, people recover from metabolic sluggishness, clear their minds, and regain health.
Indications: Primary and secondary prevention of ASCVD (MI, stroke, CAD), treatment of mixed dyslipidemia, and genetic conditions like familial hypercholesterolemia.
Panel 5: The Castle's Revenge (Adverse Effects)
The vengeful castle owners poison the Static Actor's meal, leaving him doubling over with nausea, vomiting, and abdominal pain.
Adverse Effects: Common gastrointestinal side effects include abdominal pain, nausea, diarrhea, and constipation. Other key risks include myalgia/rhabdomyolysis and elevated liver transaminases (AST/ALT).
Panel 6: The Desperate Choice (Pharmacokinetics & Interactions)
To escape, he must choose between the guarded CYP-450 Highway or the desert path guarded by the dangerous War-Fairy.
Pharmacokinetics & Drug Interactions: Atorvastatin undergoes metabolism via CYP3A4 (inhibitors like azoles/clarithromycin increase myopathy risk) and mildly interacts with Warfarin ("War-Fairy"), leading to an increased INR and risk of bleeding.
Member discussion